Novavax to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights on August 5, 2021PRNewsWire • 07/06/21
Novavax's experimental COVID-19 shot has 86.4% efficacy against the Alpha variantMarket Watch • 07/01/21
Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 VaccinePRNewsWire • 06/30/21